Anthony Harrison

891 total citations
15 papers, 536 citations indexed

About

Anthony Harrison is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Anthony Harrison has authored 15 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Anthony Harrison's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer Treatment and Pharmacology (2 papers). Anthony Harrison is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer Treatment and Pharmacology (2 papers). Anthony Harrison collaborates with scholars based in United Kingdom and United States. Anthony Harrison's co-authors include Aleksandra Galetin, Michael Gertz, J. Brian Houston, Janet Clarke, Neil R. Kitteringham, John D. Davis, J. Brian Houston, Rhys Jones, Paul Morgan and J. Brian Houston and has published in prestigious journals such as The American Journal of Medicine, Biochemical Pharmacology and Chemical Research in Toxicology.

In The Last Decade

Anthony Harrison

15 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Harrison United Kingdom 10 259 220 101 95 65 15 536
Frank W. Lee United States 13 218 0.8× 184 0.8× 173 1.7× 79 0.8× 74 1.1× 21 698
Howard Burt United Kingdom 12 337 1.3× 306 1.4× 97 1.0× 156 1.6× 65 1.0× 18 606
Joy A. Nishime United States 11 316 1.2× 283 1.3× 116 1.1× 161 1.7× 52 0.8× 14 690
Manuela Grimstein United States 9 244 0.9× 145 0.7× 93 0.9× 172 1.8× 79 1.2× 14 535
Angela Äbelö Sweden 12 195 0.8× 106 0.5× 123 1.2× 46 0.5× 72 1.1× 26 541
Yukiko Nakajima Japan 14 332 1.3× 266 1.2× 225 2.2× 97 1.0× 47 0.7× 33 790
Mikael S. Thomsen Denmark 14 304 1.2× 172 0.8× 129 1.3× 94 1.0× 67 1.0× 25 751
Ta C. Wu United States 8 301 1.2× 310 1.4× 128 1.3× 186 2.0× 114 1.8× 8 789
Sarah Shugarts United States 9 134 0.5× 259 1.2× 130 1.3× 119 1.3× 63 1.0× 13 691
Howard Miller United States 9 189 0.7× 174 0.8× 177 1.8× 62 0.7× 34 0.5× 14 556

Countries citing papers authored by Anthony Harrison

Since Specialization
Citations

This map shows the geographic impact of Anthony Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Harrison more than expected).

Fields of papers citing papers by Anthony Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Harrison. The network helps show where Anthony Harrison may publish in the future.

Co-authorship network of co-authors of Anthony Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Harrison. A scholar is included among the top collaborators of Anthony Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Harrison. Anthony Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Campion, Sarah N., Christopher Bowman, Gregg D. Cappon, et al.. (2012). Developmental Toxicity of Lersivirine in Rabbits when Administered throughout Organogenesis and when Limited to Sensitive Windows of Axial Skeletal Development. Birth Defects Research Part B Developmental and Reproductive Toxicology. 95(3). 250–261. 3 indexed citations
2.
Rawson, David J., Delphine Brugier, Anthony Harrison, et al.. (2011). Part 3: Design and synthesis of proline-derived α2δ ligands. Bioorganic & Medicinal Chemistry Letters. 21(12). 3771–3773. 6 indexed citations
3.
Johnson, Patrick S., Thomas Ryckmans, Justin S. Bryans, et al.. (2011). Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability. Bioorganic & Medicinal Chemistry Letters. 21(19). 5684–5687. 13 indexed citations
4.
Jones, Rhys & Anthony Harrison. (2011). A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats. Xenobiotica. 42(1). 75–85. 15 indexed citations
5.
Rawson, David J., Delphine Brugier, Anthony Harrison, et al.. (2011). Part 2: Design, synthesis and evaluation of hydroxyproline-derived α2δ ligands. Bioorganic & Medicinal Chemistry Letters. 21(12). 3767–3770. 3 indexed citations
6.
Harrison, Anthony, Iain Gardner, Maurice Dickins, et al.. (2011). Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms. Xenobiotica. 42(1). 57–74. 11 indexed citations
7.
Smith, Dennis A., Anthony Harrison, & Paul Morgan. (2011). Multiple Factors Govern the Association between Pharmacology and Toxicity in a Class of Drugs: Toward a Unification of Class Effect Terminology. Chemical Research in Toxicology. 24(4). 463–474. 13 indexed citations
8.
Gertz, Michael, Anthony Harrison, J. Brian Houston, & Aleksandra Galetin. (2010). Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data. Drug Metabolism and Disposition. 38(7). 1147–1158. 252 indexed citations
9.
Fray, M. Jonathan, Paul V. Fish, Gerwyn Bish, et al.. (2010). Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: Improving metabolic stability and reducing ion channel activity. Bioorganic & Medicinal Chemistry Letters. 20(12). 3788–3792. 3 indexed citations
10.
Wakenhut, Florian, Paul V. Fish, M. Jonathan Fray, et al.. (2009). N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration. Bioorganic & Medicinal Chemistry Letters. 19(17). 5078–5081. 7 indexed citations
11.
Gertz, Michael, John D. Davis, Anthony Harrison, J. Brian Houston, & Aleksandra Galetin. (2008). Grapefruit Juice-Drug Interaction Studies as a Method to Assess the Extent of Intestinal Availability: Utility and Limitations. Current Drug Metabolism. 9(8). 785–795. 51 indexed citations
12.
Galetin, Aleksandra, et al.. (2008). Comparative Analysis of CYP3A Heteroactivation by Steroid Hormones and Flavonoids in Different in Vitro Systems and Potential in Vivo Implications. Drug Metabolism and Disposition. 36(7). 1332–1340. 22 indexed citations
13.
14.
Harrison, Anthony, et al.. (1992). The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochemical Pharmacology. 43(7). 1421–1430. 83 indexed citations
15.
Ruben, Frederick L., et al.. (1984). Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen. The American Journal of Medicine. 76(1). 115–121. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank W. Lee Breakdown of academic impact, for papers by Howard Burt Breakdown of academic impact, for papers by Joy A. Nishime Breakdown of academic impact, for papers by Manuela Grimstein Breakdown of academic impact, for papers by Angela Äbelö Breakdown of academic impact, for papers by Yukiko Nakajima Breakdown of academic impact, for papers by Mikael S. Thomsen Breakdown of academic impact, for papers by Ta C. Wu Breakdown of academic impact, for papers by Sarah Shugarts Breakdown of academic impact, for papers by Howard Miller
Rankless by CCL
2026